Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PYGM | P11217 | 3/20 | 0.70 |
| ▸ | TK2 | O00142 | 4/20 | 0.65 |
| ▸ | TYMP | P19971 | 2/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.60 |
| ▸ | LMNA | P02545 | 1/20 | 0.60 |
| ▸ | ALB | P02768 | 1/20 | 0.60 |
| ▸ | POLB | P06746 | 1/20 | 0.60 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.60 |
| ▸ | BLM | P54132 | 1/20 | 0.60 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.60 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.60 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.60 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2786143 | 1.00 | PYGM (0.70) | PYGMTK2TYMPALDH1A1LMNA | |
| SCHEMBL10812613 | 1.00 | PYGM (0.70) | PYGMTK2TYMPALDH1A1LMNA | |
| SCHEMBL12103839 | 1.00 | PYGM (0.70) | PYGMTK2TYMPALDH1A1LMNA | |
| SCHEMBL14388592 | 1.00 | PYGM (0.70) | PYGMTK2TYMPALDH1A1LMNA | |
| SCHEMBL22143517 | 1.00 | PYGM (0.70) | PYGMTK2TYMPALDH1A1LMNA | |
| SCHEMBL1983444 | 1.00 | PYGM (0.70) | PYGMTK2TYMPALDH1A1LMNA | |
| SCHEMBL2583974 | 1.00 | PYGM (0.70) | PYGMTK2TYMPALDH1A1LMNA | |
| SCHEMBL10340724 | 1.00 | PYGM (0.70) | PYGMTK2TYMPALDH1A1LMNA | |
| SCHEMBL10815567 | 1.00 | PYGM (0.70) | PYGMTK2TYMPALDH1A1LMNA | |
| SCHEMBL29299 | 1.00 | PYGM (0.70) | PYGMTK2TYMPALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4537 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260139030-A1 | CHIMERIC PROTEINS FOR TREATING CUTANEOUS INFLAMMATION | SHATTUCK LABS INC (US) | 2026-05-21 | — | — | US | claimed |
| EP-4456882-B1 | LIPID-BASED FORMULATIONS FOR ADMINISTRATION OF RNA | BioNTech SE (DE) | 2026-05-13 | — | — | EP | claimed |
| US-12595282-B1 | Method for synthesizing nucleotide strands | HONGENE BIOTECH PTE. LTD. (SG) | 2026-04-07 | — | — | US | claimed |
| EP-4711452-A2 | KLOTHO MRNA | ADvantage Therapeutics, Inc. (US) | 2026-03-18 | — | — | EP | claimed |
| EP-4705481-A2 | CIRCULAR RNA COMPOSITIONS AND METHODS | Orna Therapeutics, Inc. (US) | 2026-03-11 | — | — | EP | claimed |
| EP-4696703-A2 | NUCLEIC ACID MOLECULES AND USES THEREOF | CureVac SE (DE) | 2026-02-18 | — | — | EP | claimed |
| EP-4683642-A1 | STABILIZED NUCLEIC ACID COMPOSITIONS AND METHODS FOR PREPARING, STORING AND USING THE SAME | BioNTech SE (DE) | 2026-01-28 | — | — | EP | claimed |
| US-20260021199-A1 | RNA LIPID NANOPARTICLES (LNPs) COMPRISING A POLYOXAZOLINE AND/OR POLYOXAZINE POLYMER | BioNTech SE (DE) | 2026-01-22 | — | — | US | claimed |
| US-12480117-B2 | Compositions comprising modified circular polyribonucleotides and uses thereof | FLAGSHIP PIONEERING INNOVATIONS VI, LLC (US) | 2025-11-25 | — | — | US | claimed |
| US-20250345406-A1 | CHIMERIC PROTEINS IN AUTOIMMUNITY | SHATTUCK LABS INC (US) | 2025-11-13 | — | — | US | claimed |
| EP-0673783-B1 | Recording sheets containing purine, pyrimidine, benzimidazole, imidazolidine, urazole, pyrazole, triazole, benzotriazole, tetrazole, and pyrazine compounds | XEROX CORP (US) | 2000-07-05 | — | — | EP | claimed |
| US-6017736-A | HIGH YIELD PROCESS BY BASE EXCHANGE REACTION BETWEEN PYRIMIDINE NUCLEOSIDE AND PURINE BASE IN PHOSPHATE ION-CONTAINING AQUEOUS SOLUTION IN PRESENCE OF PURINE AND PYRIMIDINE NUCLEOSIDE PHOSPHORYLASES | YUKI GOSEI KOGYO CO., LTD. (JP) | 2000-01-25 | — | — | US | claimed |
| EP-0896065-A1 | Method of preparing purine nucleoside compound | YUKI GOSEI KOGYO CO., LTD. (JP) | 1999-02-10 | — | — | EP | claimed |
| US-5659348-A | APPLYING TO A SUBSTRATE | XEROX CORPORATION (US) | 1997-08-19 | — | — | US | claimed |
| EP-0743574-A2 | Migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| EP-0743573-A2 | Method for obtaining image contrast migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| US-5563014-A | SOFTENABLE LAYER CONTAINIG PHOTOSENSITIVE MARKING MATERIAL; TRANSPARENTIZING AGENT | XEROX CORPORATION (US) | 1996-10-08 | — | — | US | claimed |
| US-5514505-A | SELECTIVE TRANSPARENTIZATION OF PHOTOSENSITIVE MIGRATION MARKING PARTICLES EMBEDDED NEAR THE SURFACE OF A SOFTENABLE LAYER SUPPORTED BY AN ELECTROCONDUCTIVE SUBSTRATE | XEROX CORPORATION (US) | 1996-05-07 | — | — | US | claimed |
| EP-0673783-A2 | Recording sheets containing purine, pyrimidine, benzimidazole, imidazolidine, urazole, pyrazole, triazole, benzotriazole, tetrazole, and pyrazine compounds | XEROX CORPORATION (US) | 1995-09-27 | — | — | EP | claimed |
| EP-0334368-A2 | Production of 2',3'-dideoxy-2',3'-Didehydronucleosides | Bristol-Myers Squibb Company (US) | 1989-09-27 | — | — | EP | claimed |